Galmed Pharmaceuticals (GLMD) Competitors $2.87 -0.03 (-1.03%) As of 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends GLMD vs. RDHL, VIRX, APM, ABVC, CNSP, GLTO, ADIL, GRI, KZIA, and EVOKShould you be buying Galmed Pharmaceuticals stock or one of its competitors? The main competitors of Galmed Pharmaceuticals include RedHill Biopharma (RDHL), Viracta Therapeutics (VIRX), Aptorum Group (APM), ABVC BioPharma (ABVC), CNS Pharmaceuticals (CNSP), Galecto (GLTO), Adial Pharmaceuticals (ADIL), GRI Bio (GRI), Kazia Therapeutics (KZIA), and Evoke Pharma (EVOK). These companies are all part of the "pharmaceutical products" industry. Galmed Pharmaceuticals vs. RedHill Biopharma Viracta Therapeutics Aptorum Group ABVC BioPharma CNS Pharmaceuticals Galecto Adial Pharmaceuticals GRI Bio Kazia Therapeutics Evoke Pharma Galmed Pharmaceuticals (NASDAQ:GLMD) and RedHill Biopharma (NASDAQ:RDHL) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation. Does the MarketBeat Community prefer GLMD or RDHL? Galmed Pharmaceuticals received 15 more outperform votes than RedHill Biopharma when rated by MarketBeat users. However, 67.24% of users gave RedHill Biopharma an outperform vote while only 63.69% of users gave Galmed Pharmaceuticals an outperform vote. CompanyUnderperformOutperformGalmed PharmaceuticalsOutperform Votes44263.69% Underperform Votes25236.31% RedHill BiopharmaOutperform Votes42767.24% Underperform Votes20832.76% Does the media favor GLMD or RDHL? In the previous week, RedHill Biopharma had 2 more articles in the media than Galmed Pharmaceuticals. MarketBeat recorded 2 mentions for RedHill Biopharma and 0 mentions for Galmed Pharmaceuticals. Galmed Pharmaceuticals' average media sentiment score of 1.00 beat RedHill Biopharma's score of 0.00 indicating that Galmed Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Galmed Pharmaceuticals Positive RedHill Biopharma Neutral Which has more risk & volatility, GLMD or RDHL? Galmed Pharmaceuticals has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500. Comparatively, RedHill Biopharma has a beta of 3.69, meaning that its share price is 269% more volatile than the S&P 500. Is GLMD or RDHL more profitable? RedHill Biopharma's return on equity of 0.00% beat Galmed Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Galmed PharmaceuticalsN/A -28.75% -24.98% RedHill Biopharma N/A N/A N/A Which has stronger earnings and valuation, GLMD or RDHL? RedHill Biopharma has higher revenue and earnings than Galmed Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGalmed PharmaceuticalsN/AN/A-$6.91M-$16.66-0.17RedHill Biopharma$6.53M1.26$23.92MN/AN/A Do institutionals & insiders hold more shares of GLMD or RDHL? 76.1% of Galmed Pharmaceuticals shares are owned by institutional investors. Comparatively, 7.2% of RedHill Biopharma shares are owned by institutional investors. 19.8% of Galmed Pharmaceuticals shares are owned by company insiders. Comparatively, 6.8% of RedHill Biopharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryRedHill Biopharma beats Galmed Pharmaceuticals on 7 of the 11 factors compared between the two stocks. Get Galmed Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for GLMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GLMD vs. The Competition Export to ExcelMetricGalmed PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.85M$6.56B$5.39B$9.14BDividend YieldN/A2.96%5.37%4.00%P/E Ratio-0.179.8288.2717.52Price / SalesN/A332.901,286.0780.21Price / CashN/A22.6336.6032.90Price / Book0.095.064.954.68Net Income-$6.91M$154.90M$117.96M$224.57M7 Day Performance2.30%2.61%2.54%3.26%1 Month Performance-5.41%1.56%3.49%5.30%1 Year Performance-28.68%5.65%27.05%22.74% Galmed Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GLMDGalmed Pharmaceuticals1.87 of 5 stars$2.87-1.0%N/A-28.3%$1.84MN/A-0.1720Positive NewsRDHLRedHill Biopharma0.2051 of 5 stars$5.69-2.9%N/A-99.0%$7.29M$3.71M-0.57210News CoveragePositive NewsVIRXViracta Therapeutics3.3214 of 5 stars$0.18-5.9%$4.05+2,214.3%-66.9%$6.96MN/A-0.1620APMAptorum Group1.0141 of 5 stars$1.34-4.0%N/A-32.4%$6.94M$431,378.000.0030Positive NewsGap UpABVCABVC BioPharma0.9018 of 5 stars$0.53-4.3%N/A-56.8%$6.88M$509,788.00-0.6230CNSPCNS Pharmaceuticals1.9843 of 5 stars$0.12+0.2%$0.50+323.7%-99.7%$6.78MN/A0.005News CoverageGLTOGalecto3.3213 of 5 stars$5.09-0.8%$10.00+96.5%-68.1%$6.70MN/A-0.2740Gap UpADILAdial Pharmaceuticals3.1598 of 5 stars$1.03+1.0%$8.00+676.7%-24.7%$6.60MN/A0.0020Positive NewsGap DownGRIGRI Bio2.7651 of 5 stars$0.72-6.2%$11.50+1,508.4%-97.1%$6.39MN/A-0.771Gap UpKZIAKazia Therapeutics3.2031 of 5 stars$1.46-7.5%$20.00+1,267.8%-59.6%$6.37M$2.31M0.0012Gap UpEVOKEvoke Pharma0.8313 of 5 stars$4.23+0.7%N/A-52.8%$6.29M$8.62M-0.384Positive News Related Companies and Tools Related Companies RDHL Competitors VIRX Competitors APM Competitors ABVC Competitors CNSP Competitors GLTO Competitors ADIL Competitors GRI Competitors KZIA Competitors EVOK Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GLMD) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galmed Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galmed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GLMD Stock Alerts